retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial results Retatrutide, a GIP, and receptor agonist Lilly's triple agonist delivers up
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15


























